24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Pharmaceuricals
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:22
Could Israel be facing an academic embargo?
17:30
Full list of Israeli startup M&As in 2024
17:26
India emerges as big winner in digital cold war between China and USA
17:09
High-tech wages surge over 12% since the start of 2024
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
2
Wiz deal to acquire Lacework collapses
3
Nvidia to acquire AI startup Deci for $300 million
4
Blackstone in advanced negotiations to acquire Priority Software in $400-500 million deal
5
Deloitte Launchpad announces seventh cohort with 10 Israeli startups
More news
Pharmaceuricals
3 stories about Pharmaceuricals
Closure of another criminal case will help Teva's new CEO to focus on return to growth
22.08.23
|
Sophie Shulman
The pharmaceutical company has reached a compromise after being suspected of price-fixing with other generic drug manufacturers in the US. In the first four years, it will pay $22.5 million and in 2028 - $135 million. In addition, the company will donate two drugs worth $50 million to humanitarian organizations
Schultz kept Teva away from the abyss, but couldn't find a runway to growth
22.11.22
|
Sophie Shulman
Kare Schultz, who served as CEO of the pharmaceutical company for the past five years, has left the company a year early after amassing a salary of more than $100 million. His replacement, Richard Francis, is taking over with less debt and less legal issues, but with the big challenge of creating new growth engines
United Therapeutics to Acquire Pharma Company SteadyMed in a $216 Deal
30.04.18
|
Amarelle Wenkert
In 2017, Israeli-founded SteadyMed won a patent war against United Therapeutics
Please ensure Javascript is enabled for purposes of
website accessibility